These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6359412)

  • 1. [Description of cytochrome p-450 research].
    Wang XL
    Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):233-7. PubMed ID: 6359412
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytochrome P-450: the effect of drugs and poisons].
    Chekman IS; Grinevich AI
    Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of the inhibition of cytochrome P-450-mediated drug oxidation by therapeutic agents.
    Murray M
    Drug Metab Rev; 1987; 18(1):55-81. PubMed ID: 3311684
    [No Abstract]   [Full Text] [Related]  

  • 4. Human cytochrome P450: possible roles of drug-metabolizing enzymes and polymorphic drug oxidation in addiction.
    Gonzalez FJ
    NIDA Res Monogr; 1991; 111():202-13. PubMed ID: 1775182
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinogens, drugs, and cytochromes P-450.
    Gelboin HV
    N Engl J Med; 1983 Jul; 309(2):105-7. PubMed ID: 6855860
    [No Abstract]   [Full Text] [Related]  

  • 7. Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.
    Pohl LR; Schulick RD; Highet RJ; George JW
    Mol Pharmacol; 1984 Mar; 25(2):318-21. PubMed ID: 6700577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines.
    Hines RN; Prough RA
    J Pharmacol Exp Ther; 1980 Jul; 214(1):80-6. PubMed ID: 7391974
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoflurane enhances dechlorination of carbon tetrachloride in guinea-pig liver microsomes.
    Fujii K; Rahman MM; Yuge O
    J Appl Toxicol; 1996; 16(3):249-53. PubMed ID: 8818866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis.
    Ioannides C; Parke DV
    Drug Metab Rev; 1993; 25(4):485-501. PubMed ID: 8313839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Features of the metabolism of various drugs involving cytochrome P-450 isoenzymes].
    Filimonova AA; Ziganshin AU; Ziganshina LE
    Eksp Klin Farmakol; 2007; 70(3):69-77. PubMed ID: 17650639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug metabolism catalyzed by cytochrome P-450].
    Nagata K
    Nihon Yakurigaku Zasshi; 2009 Sep; 134(3):146-8. PubMed ID: 19749487
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of drug metabolism: species differences and toxicological relevance.
    Graham MJ; Lake BG
    Toxicology; 2008 Dec; 254(3):184-91. PubMed ID: 18824059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-pharmacological aspects of enzyme induction].
    Bartłomowicz B
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1430-3. PubMed ID: 3913943
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug interactions with cytochrome P-450.
    Mege J
    Pa Med; 1998 Sep; 101(9):16-7. PubMed ID: 9782709
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes.
    Touw DJ
    Drug Metabol Drug Interact; 1997; 14(2):55-82. PubMed ID: 9893738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the pharmacogenetics of cytochrome P450 enzymes may affect prescribing.
    Roberts RL; Begg EJ; Joyce PR; Kennedy MA
    N Z Med J; 2002 Mar; 115(1150):137-40. PubMed ID: 12013308
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal drug metabolism.
    Lohr JW; Willsky GR; Acara MA
    Pharmacol Rev; 1998 Mar; 50(1):107-41. PubMed ID: 9549760
    [No Abstract]   [Full Text] [Related]  

  • 19. [Poisoning as toxic principle].
    Siegers CP
    Dtsch Med Wochenschr; 1978 May; 103(18):759-62. PubMed ID: 648343
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
    Gruebele A; Zawaski K; Kaplan D; Novak RF
    Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.